Dr. Eddrice McMullan praises Accuro for increasing first-attempt success rates and reducing needle passes and placement times, especially in patients with high BMI or scoliosis. “It’s genius,” she says, emphasizing its effectiveness when traditional methods fall short.
Recent Posts
- BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV
- RIVANNA’s next-generation ultrasound guidance platform and AI-driven imaging software receive FDA 510(K) clearance
- Building a Health System to Support Aging Populations [6 Steps]
- Some Studies Show Up to 25% Fewer Assisted Deliveries With Low-Dose Epidurals
- RIVANNA selected for prestigious MedTech Innovator 2025 Accelerator Cohort